NEXITO PLUS

1. Specifications & General Information
Brand Name: Nexito Plus
Generic Name: Escitalopram Oxalate and Clonazepam Tablets IP
Product Type: Prescription Medicine (Schedule H Prescription Drug)
Form Factor: Film-coated tablets
Quantity: 10 Tablets per strip
Maximum Shelf Life / Expiry Date: September 2027 (Exp. Dt.: 09/2027)
Manufacturing Date: October 2025 (Mfg. Dt.: 10/2025)
Batch Number: B.No.: SIG2239A
Maximum Retail Price (MRP): ₹127.50 (M.R.P. Rs. 127.50 incl. of all taxes per 10 Tablets)
FSSAI / Food Preference: Not Applicable (This is a prescription neuropsychiatric drug, not a dietary food product or supplement).
2. Product Details & Composition (Ingredients)
Each film-coated tablet contains:
Escitalopram Oxalate IP equivalent to Escitalopram: 5 mg
Clonazepam IP: 0.5 mg
Excipients: q.s. (Quantity Sufficient)
Colours Used: Ferric Oxide (Red) USP-NF & Titanium Dioxide IP
3. Directions for Use & Storage
Dosage: As directed by the Psychiatrist.
How to Use: Tablets should be swallowed whole with water. Do not chew, break, or crush the tablet before swallowing.
Storage Instructions: Store at a temperature not exceeding 25°C. Protect from light and moisture. Keep out of reach of children.
4. Product Description & Regulatory Warnings
Description: Nexito Plus is a central nervous system combination drug pairing a Selective Serotonin Reuptake Inhibitor / SSRI antidepressant (Escitalopram) with a benzodiazepine anxiolytic (Clonazepam). It is clinically prescribed to treat anxiety disorders, panic disorders, and symptoms of depression.
Security & Authenticity Feature: Includes a printed matrix QR code with the instruction: “Scan QR code and check product authenticity.”
Schedule H Prescription Warning: > “SCHEDULE H PRESCRIPTION DRUG – WARNING: To be sold by retail on the prescription of a Psychiatrist only.”
5. Manufacturer & Marketed By Information
Manufactured in India by: sun pharma laboratories ltd.
Manufacturing Plant Address: Plot No. 107-108, Namli Block, P.O. Ranipool, Gangtok, Sikkim-737135.
Manufacturing License Number: M.L.: M/645/2014
Marketed By: Sun Pharma Laboratories Ltd. (identified by the distinct SUN PHARMA logo and the layout text indicating “NEXITO (word) is a Registered Trademark”).